Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization (CDMO) solutions in Mainland China and internationally. I...
AsymBio breaks ground on Fengxian R&D building, targets commissioning in H2 2027
10:30 ETAsymchem's Dunhua 2 Carbapenem Manufacturing Site Successfully Completes its First FDA Inspection for Continuous Manufacturing of an API
Nomura Reaffirms Their Buy Rating on Asymchem Laboratories (Tianjin) Co., Ltd. Class H (6821)
Nomura Sees Asian Companies Seizing Global GLP-1 Receptor Agonist Opportunities, Raises TPs for WUXI APPTEC and INNOVENT BIO
Asymchem Clarifies Size of H-Share Restricted Share Grant
Asymchem Expands H Share Incentive Grants Without Diluting Shareholders